EGCG suppressed EGFR signaling and downstream phosphatidylinositol 3-kinase (PI3K)/Akt activation in the MCF-7 breast cancer cell line, resulting in down-regulation of FAS expression. This evidence concerns the gene EGFR and breast carcinoma.